SGN-00101 Vaccine

· National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGN-00101 Vaccine, covering 2013-06-03 to 2013-06-03. Get the full timeline:

Most recent: Clinical Trial Update: SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells [Phase 2]